CRITICAL
CVE-2011-2984
CWE-94Published: August 18, 2011· Updated: Jun 16, 2026
10.0
CVSS v3.1
Official Description
Mozilla Firefox before 3.6.20, SeaMonkey 2.x, Thunderbird 3.x before 3.1.12, and possibly other products does not properly handle the dropping of a tab element, which allows remote attackers to execute arbitrary JavaScript code with chrome privileges by establishing a content area and registering for drop events.
Technical Analysis
CVE-2011-2984 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
CVSS v3.1 Vector Breakdown
Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.
User Interaction
Scope
Impact
ConfidentialityC
IntegrityC
AvailabilityC
AV:N/AC:L/Au:N/C:C/I:C/A:C
Affected Vendors & Products
Mozilla3 product(s)
firefoxseamonkeythunderbird
Source: NVD CPE · 162 total CPE entries
Exploit & PoC Resources
NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.
Official Patches & Advisories
All References (20)
→
→
http://www.redhat.com/support/errata/RHSA-2011-1164.htmlVendor Advisory
Quick Facts
CVE IDCVE-2011-2984
CVSS Score10.0 / 10
SeverityCRITICAL
WeaknessCWE-94
CISA KEVNo
Affected1 vendor(s)
PublishedAug 18, 2011
Related CVEs (CWE-94)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2011-2984 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.